Introduction: Fluoroscopy use during catheter ablation procedures increases the
precision during catheter ablation and reducing radiation exposure.
However, there continues to be some reliance on fluoroscopy during ablation of complex arrhythmias. 5 In addition, prolonged standing with lead apparel has been shown to increase occupational injuries among interventional electrophysiologists. 6 Nonfluoroscopic ablation (NFA) of arrhythmias has been described and shown to be safe in the ablation of supraventricular tachycardia (SVT) and typical atrial flutter. [7] [8] [9] [10] [11] [12] [13] [14] There are reports on using NFA in paroxysmal atrial fibrillation (AF) and outflow-tract ventricular arrhythmia (VA) ablation; however, some patients required rescue fluoroscopy. [15] [16] [17] [18] [19] NFA of more complex atrial arrhythmias and VT in the setting of structural heart disease (SHD)
has not yet been described.
We describe our experience with NFA of complex arrhythmias, including left atrial (LA) arrhythmias (persistent AF and LA flutter), outflow-tract VAs, and structural VT. The techniques, challenges, and outcomes of NFA are described.
| MATERIALS AND METHODS

| Patients
Consecutive patients undergoing complex ablation by a single operator (MS) at the University of Ottawa Heart Institute were included. Baseline demographic and clinical patient characteristics including age, sex, indications for ablation, and type of arrhythmia were prospectively collected. All patients were included in a prospective research database approved by the University of Ottawa Heart Institute review board.
All ablation procedures were performed either under general anesthesia or under conscious sedation. Catheter ablation for AF or LA flutter was performed on uninterrupted warfarin anticoagulation. A single dose was withheld in subjects on direct oral anticoagulants (DOACs). 
| Operator training
During
| ICE imaging and three-dimensional mapping
ICE was performed using an 8-Fr phased-array AcuNav probe at
mHz (Siemens Medical Solutions distributed by Biosense
F I G U R E 1 ICE-guided nonfluoroscopic transseptal access. A, Following venous access, the ICE catheter is advanced towards the left atrium nonfluoroscopically by maintaining venous lumen in view (arrow) while advancing catheter. B, The fossa ovalis is visualized from the RA. C, A posterior and right-sided tilt is applied to the ICE catheter to visualize the SVC. D, A long J-wire is advanced into the SVC (arrow) followed by the long sheath over the wire and then interchanged for a BRK needle. E, A drop is performed and transseptal access is obtained by advancing the BRK needle towards the fossa ovalis. F, In the case of difficulty advancing the sheath over the dilator into the LA, the ICE catheter is advanced towards the RVOT and torqued to view the LAA and LPV ostia. Following this, a wire is advanced through the dilator and steered towards the LPV (arrow) to serve as a "rail," now the sheath can be advanced safely into the LA. ICE, intracardiac echocardiography; LA, left atrium; LAA, left atrial appendage; LPV, left pulmonary vein; RA, right atrium; RVOT, right ventricular outflow tract; SVC, superior vena cava Webster, Diamond Bar, CA). ICE imaging was used to document baseline ventricular function, valvular function, pulmonary vein flows, and the absence of a pericardial effusion. ICE was also used to visualize intracardiac structures, perform transseptal puncture, assess catheter position/contact, guide catheter movement and assess for procedural complications. In patients with a cardiac implantable electronic device (CIED), ICE was used to visualize the lead position/insertion site, and avoid interaction with the lead(s).
The CARTO electroanatomic mapping system (Biosense Webster) was used for all procedures. Online image integration and threedimensional (3D) anatomic reconstruction were performed in some patients using the phased-array ICE integration (CartoSound Module;
Biosense Webster). Ablation was performed using the NaviStar ThermoCool or ThermoCool SF catheter (Biosense Webster).
Contact force sensing catheters were used for all cases and adequate catheter-tissue contact was ensured using a combination of ICE imaging, electrogram characteristics, and contact-force sensing.
| Procedural workflow: right atrial mapping and coronary sinus access
After establishment of femoral access, the ICE catheter was advanced into the right atrium (RA), following which a baseline study examining the cardiac chambers, valves, and fossa ovalis was performed. A steerable multielectrode mapping catheter (Pentaray;
Biosense Webster) was advanced into the superior vena cava (SVC), RA, and coronary sinus (CS) to create the appropriate geometry and tag the His-bundle electrogram on the 3D map.
Subsequently, a steerable decapolar catheter was inserted into the CS under direct ICE imaging and utilizing the preformed geometry as a "road-map" to guide CS access and aid with catheter placement. In the case of difficult CS cannulation, a long preshaped Swartz SL3 sheath (St Jude Medical, St Paul, MN) was used. The SL3 sheath was advanced into the RA utilizing the same technique used to advance the steerable sheath into the SVC before transseptal access (see below).
| Procedural workflow: transseptal access
The ICE catheter was placed in the RA and the fossa ovalis was visualized. Next, a posterior and right-sided tilt of the ICE catheter was performed to visualize the SVC ( Figure 1 and Video 1).
A long J-wire was passed from the right femoral vein to the SVC, followed by advancement of a long steerable sheath (Agilis NxT, St
Jude Medical) over the wire into the SVC (under ICE visualization). A BRK needle (St Jude Medical) was advanced into the sheath and the apparatus was pulled back to the fossa ovalis, following which the transseptal puncture was performed under ICE guidance.
| Procedural workflow: retrograde aortic access
The ICE catheter was advanced into the right ventricular outflow tract (RVOT) to visualize the aortic root. Arterial femoral puncture 2.7 | Ablation protocol: AF and LA flutter
All LA ablation procedures were performed under general anesthesia.
Following insertion of the ICE probe, transseptal access was performed (see above).
Subsequently the multielectrode mapping catheter was advanced into the LA to create LA geometry, following which it was interchanged for the ablation catheter and ablation was performed. 
| Statistical analysis
Categorical variables are reported as number (%) and were compared using χ 2 tests. Continuous variables are reported as mean ± SD and were compared using t tests. Based on preliminary data on procedure duration for 20 cases using fluoroscopy and 10 cases without fluoroscopy, we estimated that 50 nonfluoroscopic cases would afford 80% power to confirm noninferiority in procedure duration using a margin of 10% of baseline and a one-sided α level of 0.05. This 10% increase in procedure time for nonfluoroscopic cases was deemed clinically acceptable by all authors before data analysis. The first 20 nonfluoroscopic cases performed were excluded from the noninferiority analysis for minimizing the influence of the "learning curve" expected with a change in ablation strategy but were included in temporal analyses. Temporal patterns in procedure duration were evaluated using Spearman's rank correlation coefficient and t tests for consecutive groups of 10 cases. All analyses were performed using SAS 9.4 (SAS Institute, Cary, NC). Excepting the noninferiority analysis, all comparisons used two-sided α levels of 0.05 to define statistical significance.
| RESULTS
Between July 2016 and May 2018, all eligible patients (80) were ablated using this protocol.
| Clinical characteristics
Baseline patient characteristics are listed in Table 1 . Of the 80 patients, 57 (71.3%) were male, and the mean age was 60.1 ± 9.9 years. Thirty-nine patients underwent ablation for complex LA SADEK ET AL. However, we also include 31 patients with paroxysmal AF to provide additional data on the procedure duration/learning curve and to make the series fully consecutive.
All 80 patients underwent ablation procedures nonfluoroscopically with the guidance of ICE imaging and electroanatomic mapping.
Physicians and nursing staff wore no lead apparel during these procedures and no lead barriers were used. All procedures were completed without the need for rescue fluoroscopy. The 80 patients were followed for an average of 11.3 ± 6.6 months postablation.
| CS access
CS catheter placement was successful in all 80 cases with proximal electrode placement at or beyond the CS ostium. In eight cases, the use of a SL3 sheath was required to advance the CS catheter, as detailed in Section 2. Three patients had a mitral-annular flutter and three had a roofdependent flutter. All patients in this group had either undergone previous cardiac surgery (n = 5) or had prior ablation procedures (n = 1). Patients with VAs in the setting of SHD (n = 6) are described in Table 2 . Four underwent LV ablation via the retrograde aortic route, one via the transseptal route, and one underwent RV ablation. All patients had elimination of clinical VT at procedure end, and one patient had VT recurrence the day following the procedure that responded to initiation of sotalol.
| NFA of VAs
| Transseptal access
In total, 71 patients underwent nonfluoroscopic transseptal puncture. The first five patients underwent double transseptal access using ICE guidance; however, significant reverberation artifact was noted after the first transseptal (Figure 3) , which made the second transseptal puncture challenging. Subsequently, a decision was made to change to a single transseptal access for AF cases and double transseptal access for LA flutter cases.
There were seven cases where septal thickening impeded the advancement of the needle through the interatrial septum. In these cases, electrocautery was applied to the proximal end of the BRK needle to allow for septal cauterization and the apparatus was then advanced into the LA.
In 15 cases, there was difficulty advancing the sheath over the needle/dilator into the LA. The ICE probe was placed in the RVOT to visualize the left pulmonary veins (LPVs), and this view was used to advance the J-wire through the dilator and into the LPVs ( Figure 1F ).
The J-wire would serve as a "rail" to advance the apparatus safely over the wire with further pressure.
In two cases, we were unable to pass the long J-wire into the SVC before transseptal access. In one case, the long J-wire would coil within the RA/RV and could not be advanced into the SVC. In the other case, we could not visualize the wire advance into the heart. In both cases, the Agilis sheath was placed in the inferior vena cava and the ablation catheter was advanced through it and visualized on the mapping system.
Following this, the ablation catheter was advanced slowly toward the RA and SVC using the mapping system, and the steerable sheath was advanced over the ablation catheter into the SVC. At this point, the wire and dilator were advanced through the sheath and the transseptal procedure was performed as described above.
In one case, once the apparatus was dropped from the SVC, it was no longer visible and could not be identified on the interatrial septum despite repeated attempts. At this point, the ablation catheter was advanced through the sheath and directly guided onto the fossa ovalis using ICE imaging. Following this, the sheath was advanced onto the fossa and the ablation catheter was removed. Subsequently, the dilator and BRK needle were advanced through the Agilis sheath and directly onto the interatrial septum. At this point, the transseptal puncture was performed in standard fashion.
| Patients with CIEDs
Five patients had a CIED present, of which three were singlechamber devices and two were dual-chamber devices. In these cases, care was taken not to dislodge the leads during catheter insertion into the heart or during transseptal access. The RA and RV lead bodies and insertion points were visualized using ICE imaging and contoured using phased-array ICE integration (Figure 4) . Care was taken to visualize the RA lead at pullback during transseptal access, and the angle of the sheath was maintained away from the RA lead.
At case end, the leads were visualized again and there were no changes in position. Device interrogation was performed before and after the procedure and stable lead parameters were confirmed.
| Procedural time
The total procedural times for 20 cases with fluoroscopy immediately before transitioning to nonfluoroscopy were used as baseline (229 ± 38 minutes). Excluding the first 20 nonfluoroscopic cases (to allow for operator learning) and using a predetermined 23-minute noninferiority margin (10% of baseline procedure duration), the transition to NFA was not associated with an increase in procedural time (225 ± 32 minutes; P = 0.002 for noninferiority). When analyzed over time, there was an initial and immediate increase in procedural time upon transitioning to nonfluoroscopy with a downward trend to nonsignificance after the first 20 cases (P = 0.996; Figure 5 ).
| Procedural outcomes and complications
Of the 34 patients with atrial arrhythmias with more than 1 year of follow-up and after a mean follow-up of 18.1 ± 3.6 months (range 12 to 24 months), freedom from atrial arrhythmias was achieved in 31 (91.2%) patients.
For patients with VAs in the absence of SHD, all four had a significant reduction of VPD burden to less than 1% at follow-up. For patients with VAs in the setting of SHD, acute outcomes are listed in Table 1 . At 3 months postablation, five patients (83%) were free of sustained arrhythmias or device therapies.
There were no intraprocedural complications. One patient had persistent sinus bradycardia postablation of persistent AF, requiring pacemaker insertion 2 days postprocedure.
| DISCUSSION
In this paper, we describe our technique, workflow, and acute the ability of reducing fluoroscopic times to less than 5 to 10 minutes. 5, 22, 23 However, there is a linear relationship between dose and increased future risk of malignancy, with no dose threshold below which radiation exposure does not contribute to risk. 24 The concept that radiation exposure should be minimized is the foundation of the ALARA principle that radiation exposure should always be maintained "As Low As Reasonably Achievable." This is especially true for children, young adults, and pregnant patients who are more sensitive to radiation and, for a given exposure, have a greater risk of radiation-induced stochastic events compared with the elderly. In addition, obese patients are at a particularly high risk due to the higher radiation dose requirements for adequate fluoroscopic imaging. 24 Eliminating fluoroscopy is also advantageous to the operators and staff. Cardiac electrophysiologists have an annual ionizing radiation exposure 2 to 3 times higher than diagnostic radiologists, which can theoretically result in a cumulative risk of one extra cancer for every 100 exposed individuals after a full professional career. 1, 3, 25 An excess risk of brain tumors, breast cancer in female cardiologists (predominantly on the left side, which is usually exposed to the radiation source) and cataracts has been reported, and is probably related to the increased radiation exposure in interventional cardiologists and electrophysiologists. [26] [27] [28] Given these risks, there has been increasing interest in strategies to reduce radiation exposure to both patients and operators. 5, 22 In addition, occupational injuries relating to the wearing of lead apparel have been reported, 6 and eliminating the need for lead protection can reduce such injuries.
| NFA of LA arrhythmias
Nonfluoroscopic PVI for paroxysmal AF has been reported utilizing ICE imaging, intracardiac electrograms, and electroanatomic mapping. Ferguson et al demonstrated that NFA of AF was feasible and safe in 21 cases; however, they required fluoroscopic rescue for two cases to aid with transseptal puncture (with 2-16 minutes of fluoroscopy used for these procedures). 15 Rotational ICE was used in their study, which differs from the standard phased-array ICE used in most electrophysiologic procedures and in our study. Reddy et al, 16 Bulava et al, 17 and Lyan et al 18 Our data show that although NFA of left atrial arrhythmias is feasible, there is a learning curve to consider, and procedural duration does improve with increasing operator experience. This is an important point for ablation programs that are considering transition to a NFA approach, as extra procedural time may need to be allotted to the operators to familiarize themselves with the unique challenges they may encounter.
| NFA of VAs
Reduction of fluoroscopic exposure has been shown with the use of fluoroscopy image integration modules (IIM, CartoUnivu Module). 29 With this technology, radiation exposure was reduced to less than 10 minutes, and patients with nonischemic cardiomyopathy or those needing epicardial access required more fluoroscopic exposure. NFA has been performed in patients with idiopathic VT in a series, 19 showing similar procedural efficacy and times, in addition to reduced staff fatigue due to not wearing lead apparel. However, 5.6% of cases required switching to a fluoroscopic approach.
NFA of structural VT presents a different set of challenges, including the presence of device leads with the risk of lead dislodgement, the need to safely access the LV via either the transseptal or retrograde aortic approach, and the potential increased risk of procedural complications. These challenges can be addressed as shown in our approach to avoiding leads and using ICE imaging to guide the catheter into the LV and assess the substrate. To our knowledge, this is the first series to report on NFA of VT in the setting of SHD. however, such reports are usually limited to SVT treatment. NFA has been also reported in patients with SVT and VPDs. 31, 32 Ablation of VT in patients with SHD is often a longer procedure, uses more fluoroscopy, and may require general anesthesia. There has been a reported VT ablation in a pregnant patient with ARVD performed at 36 weeks of gestation. 33 However, there is a concern of fetal exposure to radiation which may result in fetal abnormalities including intellectual disability (especially with doses above 50 mGy). 34, 35 Given the above information, VT ablation in pregnant patients is considered as a last resort in medically refractory patients with lifethreatening arrhythmias. 36 In the case that patients do require ablation, we feel that a nonfluoroscopic approach is ideal. In our particular case, endocardial ablation was performed in a pregnant patient with ARVD and electrical storm under conscious sedation, thus minimizing the iatrogenic effect.
| Alternative imaging modalities
Although our preferred imaging modality during NFA of complex arrhythmias is ICE imaging, there are certain disadvantages, which include catheter cost and operator experience. The use of a transesophageal echocardiograph (TEE) to guide transseptal puncture is well described, has been shown to be useful, and is the imaging modality of choice at many centers. 37 The use of TEE to perform NFA of AF has been described with good outcomes, 38 and is an excellent alternative in centers where ICE imaging is not used or is unavailable. Disadvantages of TEE imaging include the need for a dedicated operator for image acquisition and interpretation. In addition, in some patients, TEE may not be possible or may be associated with increased risk. A limitation identified in our study is the challenge in performing a double transseptal puncture due to reverberation artifact. Although this is possible, careful assessment of the ICE image to account for the artifact and accurate visualization of the transseptal apparatus is key.
Other limitations that are possible but not encountered in our patient cohort include:
(1) Patients with a CS lead for the purposes of cardiac resynchronization therapy: although we were able to visualize the body of the RA/RV leads in our patient population for preventing inadvertent dislodgement during catheter manipulation, a CS lead is more difficult to identify without fluoroscopy. Hence, although NFA is feasible, there is a risk of CS lead dislodgement that can only be identified at device interrogation or by radiological imaging postprocedure. 
| CONCLUSIONS
NFA of complex arrhythmias, including persistent AF, LA flutter, and VT (with and without structural heart disease) is feasible. There is an initial learning curve when transitioning to NFA, following which procedure times are comparable to fluoroscopy-guided ablation.
